The two peptides have separate FDA concerns: FDA flagged CJC-1295 for limited clinical data and serious adverse events including increased heart rate and systemic vasodilatory reaction
Storage: To maintain the peptides effectiveness over time, containers must be kept tightly closed
Academic Press, London, pp 319 Kranner I (1998) Determination of glutathione, glutathione disulphide and two related enzymes, glutathione reductase and glucose-6-phosphate dehydrogenase, in fungal and plant cells
Journal of Diabetes and Metabolism
Do not use it for human consumption
compared ALT-801 (another dual GLP-1/GCG receptor agonist), semaglutide and elafibranor in AMLN diet NAFLD mouse model to validate the beneficial effects of GLP-1/GCG dual agonism in NAFLD hepatic outcomes